Health

Scar Treatment Market Size, Status and Forecast 2018-2026

Press Release

New product launches for scar treatment by key players is a major factor expected to propel growth of the global scar treatment market. For instance, in 2016, Win Medicare Ltd. launched Contractubex – a medical solution to treat scars. This product aids in treatment of normal wound scars by improving their appearance. It makes the scars smoother, more functional, elastic, strong, and less noticeable.

Furthermore, collaborations between key players is expected to drive global scar treatment market growth. For instance, in February 2018, Sensus Healthcare Inc., a medical device company— collaborated with Birch BioMed Inc., a biomedical company, to treat and prevent scarring more effectively for patients who are afflicted with keloids.

Approval of new products by FDA is also expected to drive growth of the scar treatment market. For instance, in 2013, Sensus Healthcare received approval from FDA for its SRT-100 device. The device utilizes sharp beam technology, which is a superficial radiotherapy innovation that first isolates and then targets the affected skin. This keloid scar removal treatment does not affect the surrounding and underlying healthy skin and tissues.

Scar Treatment market Regional analysis:-

North America is expected to be dominant in global scar treatment market over the forecast period. This is due to launch of new products in the region. For instance, in 2017, Herborium Group Inc., a botanical therapeutics company, launched Rejuvel 3D. This is a topical acne scar product, which has plant cells and antigravity technology that helps in reducing and eliminating acne scars, spots and marks, while moisturizing and rejuvenating the skin.

Download the PDF brochure:

https://www.coherentmarketinsights.com/insight/request-pdf/1993

Europe scar treatment market is expected to show significant growth over the forecast period, due to launch of new products for scar treatment by key players in the market. For instance, in 2017, Fagron NV, an innovative pharmaceutical compounding company launched Nourisil MD Silicone scar gel in the U.K. This silicone gel aids in flattening, smoothening, and softening of keloids, and hypertrophic scars due to its unique formula of five different silicones and vitamin E. Nourisil MD Silicone scar gel is a skin- friendly product and can aid in treating scars in children.

Scar Treatment Market Key Players:-

Key players operating in the global scar treatment market include Merz Inc., Lumenis Ltd., Smith & Nephew Plc., Sonoma Pharmaceuticals Inc., Enaltus LLC., Scarheal Inc., Molnlycke Healthcare, CCA Industries Inc., and Cynasure Inc.

Market players are focusing on launching innovative products, in order to enhance their market share. For instance, in 2015, the editors of TotalBeauty.com recognized Mederma® PM Intensive Overnight Scar Cream, as breakthrough product. Mederma is a topical product, which aids in treating scars on the face and body due to injury, acne, surgery, and others.

Furthermore, major companies are launching campaigns, in order to treat patients with scars and wounds. This is expected to aid in increasing customer base of the company. For instance, in 2016, Lumenis Ltd., an energy-based medical device company for aesthetic, surgical, and ophthalmology applications, launched a campaign -Restoring Heroes Foundation. This foundation helps in treating scars and wounds of American soldiers. Such campaigns are expected to fuel the scar treatment market growth.

Get HOLISTIC Request Sample Copy Of This Business Report:

https://www.coherentmarketinsights.com/insight/request-sample/1993

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:[email protected]

RSS news